• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Aug 1, 2012; 122(8): 2768–2770.
Published online Jul 23, 2012. doi:  10.1172/JCI65208
PMCID: PMC3408759

Memory CD4+ T cells: beyond “helper” functions

Abstract

In influenza virus infection, antibodies, memory CD8+ T cells, and CD4+ T cells have all been shown to mediate immune protection, but how they operate and interact with one another to mediate efficient immune responses against virus infection is not well understood. In this issue of the JCI, McKinstry et al. have identified unique functions of memory CD4+ T cells beyond providing “help” for B cell and CD8+ T cell responses during influenza virus infection.

Efficient control and clearance of viral infections requires coordinated interactions of several components of the immune system. Over the past 10 years, Susan Swain and colleagues have elucidated several functions of memory CD4+ T cells during influenza A virus (IAV) infection. They demonstrated the role of memory CD4+ T cells in innate immune responses (1, 2), in the enhancement of B cell responses by follicular helper T (TFH) cells via Signaling Lymphocyte Activation Molecule (SLAM)-associated protein (SAP) expression (3), and in direct antiviral effects via a perforin–mediated cytotoxic mechanism (4, 5). In this issue of JCI, the Swain group, led by Kai McKinstry, systematically transferred memory CD4+ T cells into mice deficient in specific lymphocyte populations and elegantly dissected the mechanisms by which memory CD4+ T cells protect against IAV infection in mice (6). They report three new findings (Figure (Figure1).1). First, the innate antiviral functions of memory CD4+ T cells are IFN-γ dependent and independent of the pathogen recognition receptor (PRR) pathway (Figure (Figure1A).1A). Second, memory CD4+ T cells enhance B cell responses independently of TFH cells and germinal center formation (Figure (Figure1B).1B). Third, in addition to mediating effector functions via a perforin-dependent pathway (Figure (Figure1C),1C), memory CD4+ T cells use the same pathway to drive selection of escape mutants for a process that was known to occur in CD8+ T cells (Figure (Figure1D).1D). These new findings are discussed below.

Figure 1
Memory T cell functions demonstrated during IAV infection.

Toward a better understanding of memory CD4+ T cell immunity to influenza virus

During primary influenza infection, CD4+ T cells provide help in promoting antibody production by B cells and are required for the generation of cytotoxic and memory CD8+ T cells (7). After the infection is resolved, the majority of effector CD4+ T cells undergo apoptosis, leaving behind a small population of memory CD4+ T cells, which respond more rapidly and effectively during reinfection. Several studies have suggested additional roles of memory CD4+ T cells during influenza reinfection, including enhancement of innate immune responses (1) as well as non-helper antiviral functions (8).

In the current study, McKinstry et al. demonstrate the role of memory CD4+ T cells in immune protection from IAV infection. Memory CD4+ T cells protect mice that lack T or B cells, though CD8+ T cells are needed between days 6 and 10 after infection for viral clearance in B cell–deficient mice (6, 9). McKinstry et al. demonstrated that the protection conferred by memory CD4+ T cells in mice that lack both T and B cells is incomplete; mice can be protected against low-dose viral challenge but not against high-dose challenge. Memory CD4+ T cells mediated protection against low-dose influenza infection via IFN-γ production independently of other lymphocytes. The authors also found that to clear infection following a high dose of challenge virus, memory CD4+ T cells interacted with naive B cells and CD8+ T cells. The reduction in morbidity and mortality in the recipient mice was convincing, but the reduction in viral titers (expressed as polymerase [PA] gene copies) was very modest, though statistically significant (6). A relatively small change in pulmonary virus titer can be associated with remarkable differences in mortality in IAV infection in mice (10). In agreement with this study, preexisting memory CD4+ T cells have also been shown to correlate with disease protection against influenza challenge in humans (1113).

Direct role of memory CD4+ T cells in virus infection

Although the most well-characterized function of memory CD4+ T cells during viral infection is the maintenance of B cell and CD8+ T cell responses, several other roles of memory CD4+ T cells have been elucidated in IAV infection (14). Recent studies have shown that memory CD4+ T cells, but not naive CD4+ T cells, enhance the production of multiple innate inflammatory cytokines and chemokines in the lungs of infected mice and lead to early control of influenza virus infection. Interestingly, McKinstry et al. show, in agreement with previous publications, that innate immune responses mediated by memory CD4+ T cells are PRR independent (1, 6). This is important because influenza viruses can evade immune protection by antagonizing key components of the PRR pathway (15).

Memory CD4+ T cells synergize with other lymphocytes

The CD4+ T cells that enter B cell follicles and provide help to B cells are referred to as TFH cells. Following viral infection, TFH cells express SAP to direct the formation of germinal centers (16), where they promote the formation of memory B cells and long-lived antibody-producing plasma cells. Memory CD4+ T cells are superior to naive T cells in providing help to B cells: they promote earlier B cell proliferation, higher antibody levels, and earlier antibody class switching (1719). Interestingly, McKinstry et al. show that, unlike naive CD4+ T cells, enhancement of B cell responses by memory CD4+ T cells is not dependent on a TFH-associated pathway.

Priming of CD8+ T cells by memory CD4+ T cells during IAV infection has been studied extensively (2022), but the role of memory CD4+ T cells as cytotoxic effectors is less certain. This group has shown previously that memory CD4+ T cells mediate cytotoxicity by a perforin-dependent mechanism (4). Here, Mc­Kinstry et al. extended these findings by showing that memory CD4+ T cells select for influenza escape mutants and that this selection requires perforin. This mechanism is similar to that by which CD8+ T cells select for escape variants (23).

Questions and future challenges

While the work by McKinstry et al. provides novel insights into cellular mechanisms by which memory CD4+ T cells contribute to immune protection against influenza, several questions remain. Areas that warrant further study include the PRR-independent protection elicited by memory CD4+ T cells via production of IFN-γ in the absence of other lymphocytes and the synergy of memory CD4+ T cells with B cells independent of TFH cells. Interestingly, Th17 cells also provided protection in this study, but their function was not well characterized. The precise role of Th17 in this complex network should be explored further. Although the authors discuss the role of memory CD4+ T cells in heterosubtypic immunity (24), the experiments in the current study only evaluated protection from homologous viral challenge. Further study of the role of memory CD4+ T cells in heterosubtypic immunity is needed. The authors close with the suggestion that vaccines that elicit memory CD4+ T cell responses in addition to antibodies may offer universal protection against seasonal and pandemic influenza viruses. An exploration of approaches to achieve this result, e.g., by administration of influenza vaccines with oil-in-water adjuvants (25), would be of interest. Last but not least, while it is clear that such reductionist approaches are of great value in dissecting the pathways, it is not clear how translatable the findings will be from mice to humans.

Acknowledgments

The authors are supported by the Intramural Research Program of NIAID, NIH.

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Citation for this article: J Clin Invest. 2012;122(8):2768–2770. doi:10.1172/JCI65208.

See the related article beginning on page 2847.

References

1. Strutt TM, et al. Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med. 2010;16(5):558–564. doi: 10.1038/nm.2142. [PMC free article] [PubMed] [Cross Ref]
2. Strutt TM, McKinstry KK, Swain SL. Control of innate immunity by memory CD4 T cells. Adv Exp Med Biol. 2011;780:57–68. [PMC free article] [PubMed]
3. Kamperschroer C, Swain SL, Grussenmeyer T, Lefkovits I. SAP deficiency results in a striking alteration of the protein profile in activated CD4 T cells. J Proteome Res. 2006;5(7):1785–1791. doi: 10.1021/pr0600778. [PubMed] [Cross Ref]
4. Brown DM, Dilzer AM, Meents DL, Swain SL. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol. 2006;177(5):2888–2898. [PubMed]
5. McKinstry KK, et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol. 2009;182(12):7353–7363. doi: 10.4049/jimmunol.0900657. [PMC free article] [PubMed] [Cross Ref]
6. McKinstry KK, et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. . J Clin Invest. 2012;122(8):2847–2856. doi: 10.1172/JCI63689. [PMC free article] [PubMed] [Cross Ref]
7. Topham DJ, Doherty PC. Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol. 1998;72(1):882–885. [PMC free article] [PubMed]
8. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol. 2010;84(18):9217–9226. doi: 10.1128/JVI.01069-10. [PMC free article] [PubMed] [Cross Ref]
9. Miao H, et al. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J Virol. 2010;84(13):6687–6698. doi: 10.1128/JVI.00266-10. [PMC free article] [PubMed] [Cross Ref]
10. Epstein SL, et al. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J Immunol. 1997;158(3):1222–1230. [PubMed]
11. Lee LY, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest. 2008;118(10):3478–3490. [PMC free article] [PubMed]
12. Wilkinson TM, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18(2):274–280. doi: 10.1038/nm.2612. [PubMed] [Cross Ref]
13. Schmidt T, et al. Eur J Immunol. CD4(+) T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection [published online ahead of print May 14, 2012]. doi: 10.1002/eji.201242393 . [PubMed]
14. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol. 2011;12(2):136–148. [PMC free article] [PubMed]
15. Min JY, Li S, Sen GC, Krug RM. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology. 2007;363(1):236–243. doi: 10.1016/j.virol.2007.01.038. [PubMed] [Cross Ref]
16. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature. 2003;421(6920):282–287. doi: 10.1038/nature01318. [PubMed] [Cross Ref]
17. MacLeod MK, David A, McKee AS, Crawford F, Kappler JW, Marrack P. Memory CD4 T cells that express CXCR5 provide accelerated help to B cells. J Immunol. 2011;186(5):2889–2896. doi: 10.4049/jimmunol.1002955. [PMC free article] [PubMed] [Cross Ref]
18. Bradley LM, Croft M, Swain SL. T-cell memory: new perspectives. Immunol Today. 1993;14(5):197–199. doi: 10.1016/0167-5699(93)90161-D. [PubMed] [Cross Ref]
19. Croft M, Swain SL. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J Immunol. 1995;154(9):4269–4282. [PubMed]
20. Topham DJ, Tripp RA, Doherty PC. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol. 1997;159(11):5197–5200. [PubMed]
21. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188(12):2199–2204. doi: 10.1084/jem.188.12.2199. [PMC free article] [PubMed] [Cross Ref]
22. Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol. 2004;4(8):595–602. [PubMed]
23. Price GE, Huang L, Ou R, Zhang M, Moskophidis D. Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus. J Virol. 2005;79(13):8545–8559. doi: 10.1128/JVI.79.13.8545-8559.2005. [PMC free article] [PubMed] [Cross Ref]
24. McKinstry KK, Strutt TM, Swain SL. Hallmarks of CD4 T cell immunity against influenza. J Intern Med. 2011;269(5):507–518. doi: 10.1111/j.1365-2796.2011.02367.x. [PMC free article] [PubMed] [Cross Ref]
25. Galli G, et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A. 2009;106(10):3877–3882. doi: 10.1073/pnas.0813390106. [PMC free article] [PubMed] [Cross Ref]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...